Patients beliefs on intravenous and subcutaneous routes of administration of biologics for severe asthma treatment: A cross-sectional observational survey study
Background: Understanding how patients generate preferences for administration route alternatives may improve health-care delivery and clinical outcomes. Recently, novel biological therapies with subcutaneous (SC) and intravenous (IV) administration routes have been approved for severe uncontrolled...
Main Authors: | Pierachille Santus, Matteo Ferrando, Ilaria Baiardini, Dejan Radovanovic, Alice Fattori, Fulvio Braido |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | World Allergy Organization Journal |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455119301188 |
Similar Items
-
The evidence on tiotropium bromide in asthma: from the rationale to the bedside
by: Dejan Radovanovic, et al.
Published: (2017-05-01) -
Erratum to: The evidence on tiotropium bromide in asthma: from the rationale to the bedside
by: Dejan Radovanovic, et al.
Published: (2017-06-01) -
The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection
by: Jin JF, et al.
Published: (2015-07-01) -
Payer Perspectives on Intravenous versus Subcutaneous Administration of Drugs
by: Epstein RS
Published: (2021-09-01) -
Failure in Asthma Control: Reasons and Consequences
by: Fulvio Braido
Published: (2013-01-01)